Radiolabeling, Preparation, and Bioevaluation of 99mTc-Azathioprine as a Potential Targeting Agent for Solid Tumor Imaging
- Autores: Sanad M.H.1, Marzook F.1, Saleh G.M.2, Farag A.B.3, Talaat H.M.1
-
Afiliações:
- Labeled Compounds Department, Hot Laboratories Center
- Health Radiation Research Department (Radio diagnosis Unit), National Center for Radiation Research and Technology
- Pharmaceutical Chemistry Department, Faculty of Pharmacy
- Edição: Volume 61, Nº 4 (2019)
- Páginas: 478-482
- Seção: Article
- URL: https://ogarev-online.ru/1066-3622/article/view/225253
- DOI: https://doi.org/10.1134/S106636221904012X
- ID: 225253
Citar
Resumo
Azathioprine, an antitumor agent, was labeled with 99mTc using stannous chloride dihydrate as a reducing agent. Factors such as the amounts of the reducing agent and substrate, pH, and reaction temperature and time were systematically studied to determine the optimum conditions, under which the 95% radiochemical yield was achieved. Biodistribution studies demonstrate the suitability of 99mTc-azathioprine as a novel tracer for tumor imaging. It shows high selectivity to high-replicating solid tumors.
Palavras-chave
Sobre autores
M. Sanad
Labeled Compounds Department, Hot Laboratories Center
Autor responsável pela correspondência
Email: drsanad74@gmail.com
Egito, Cairo
F. Marzook
Labeled Compounds Department, Hot Laboratories Center
Email: drsanad74@gmail.com
Egito, Cairo
G. Saleh
Health Radiation Research Department (Radio diagnosis Unit), National Center for Radiation Research and Technology
Email: drsanad74@gmail.com
Egito, Cairo
A. Farag
Pharmaceutical Chemistry Department, Faculty of Pharmacy
Email: drsanad74@gmail.com
Egito, Giza
H. Talaat
Labeled Compounds Department, Hot Laboratories Center
Email: drsanad74@gmail.com
Egito, Cairo
Arquivos suplementares
